ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects

Combination of Curio Seeker with Precision Health Data Cloud provides scientists with a secure and scalable solution for managing and sharing high-resolution, spatially resolved gene expression data

DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Curio Bioscience today announced a collaboration to streamline and simplify data analysis for high-resolution, whole transcriptome spatial mapping studies. As part of the agreement, Curio Seeker Spatial Mapping Kit customers will be able to use the DNAnexus Precision Health Data Cloud and its intuitive analysis environment to process the unbiased Curio Seeker data sets across different tissue types and species to fuel basic research and accelerate scientific discovery.

Curio Seeker is the first high-resolution, whole transcriptome spatial mapping solution that offers the ability to generate molecular images of tissue sections by capturing and mapping the spatial location of RNA molecules using next-generation sequencers. The DNAnexus Precision Health Data Cloud provides customers with a secure, streamlined, and scalable option for managing, analyzing, and sharing large-scale multi-omic data. The combined solution allows researchers to accelerate the understanding of cellular functions in the context of their native environment and gain additional biological insights that are not available from single-cell RNA sequencing approaches.

“This collaboration with DNAnexus provides our customers with a fully integrated, easy-to-use, and scalable cloud-based environment for accessing and analyzing the rich, whole transcriptome, and high resolution spatial data sets generated by the Curio Seeker workflow,” said Christina Fan, PhD, Co-founder and Chief Technology Officer at Curio Bioscience. “The Precision Health Data Cloud streamlines the process for biologists by making primary data analysis easy to initiate without support from bioinformaticians or investment in computing infrastructure. This partnership with DNAnexus aligns with our overall mission to make complex spatial biology measurements more accessible to the research community.”

Today, DNAnexus has more than 45,000 registered users across 48 countries and actively manages and supports more than 105 petabytes of complex clinical genomic, proteomic, and other multi-omic datasets on behalf of a growing network of collaborators. Its comprehensive cloud platform meets the most rigorous industry standards for data quality, security, privacy, and regulatory compliance.

“DNAnexus is committed to building a complete ecosystem of forward-thinking technology providers like Curio Bioscience that will shape the future of life science research,” said Thomas Laur, CEO at DNAnexus. “Customers using the Curio Seeker with our Precision Health Data Cloud will be able to harness the full potential of their high-resolution spatial transcriptomics data to accelerate scientific research and discovery.”

About Curio Bioscience

Curio Bioscience is advancing a new generation of high-precision tools for the life sciences industry. The company has developed innovative spatial biology capabilities to map the whole transcriptome at high resolution using existing sequencing workflows and instrumentation. The founding team has a strong track record of bringing genomic solutions to market. Based in Palo Alto, California, Curio Bioscience is a privately held company. For more information, visit www.curiobioscience.com.

About DNAnexus

DNAnexus enables biomedical organizations to accelerate scientific discovery and improve patient care with the Precision Health Data Cloud. The company provides scientific innovators and healthcare professionals with the ability to manage, analyze, and collaborate on multi-omic, clinical, and real-world data to unlock insights. DNAnexus actively manages more than 105 petabytes of data on behalf of a growing network of collaborations with leading pharmaceutical, clinical diagnostic, academic research, biobank, and government organizations. Today, more than 45,000 users across 48 countries and over 130 enterprise customers are harnessing the full potential of their data with the scalable and secure Precision Health Data Cloud. DNAnexus is headquartered in Mountain View, Calif. For more information, visit www.dnanexus.com or follow @DNAnexus.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.